KBC Securities advice for IBA
| Date | Bank | Stock | Advice | Price | Difference |
|---|---|---|---|---|---|
| February 01, 2022 | KBC Securities | IBA | Buy | 17.50 EUR | 5.26 % |
Advice details
Brussels - Op 01 feb verhogen de analisten hun advies voor het Belgische biofarmaceutische bedrijf IBA (ISIN: BE0003766806 / Mnemo: IBAB) van Houden naar Kopen. Het 12-maands koersdoel blijft gehandhaafd op 17.5 EUR.
Last KBC Securities advice for IBA
| Date | Bank | Stock | Advice | Price | Difference |
|---|---|---|---|---|---|
| February 01, 2022 | KBC Securities | IBA | Buy | 17.50 EUR | 5.26 % |
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
|
©2024 ValueSpectrum. All Rights Reserved
Developed and maintained by 